News for Sangamo BioSciences, Inc. (SGMO)

News for Sangamo BioSciences, Inc.
Date Headline
Mar 21, 2017 09:26 AM Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar 20, 2017 05:08 PM SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar 14, 2017 02:30 PM Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar 07, 2017 01:04 PM SANGAMO THERAPEUTICS, INC Financials
Mar 01, 2017 04:05 PM Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference
Mar 01, 2017 08:30 AM Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Feb 28, 2017 07:53 AM Sangamo reports 4Q loss
Feb 28, 2017 07:53 AM Sangamo reports 4Q loss
Feb 28, 2017 07:07 AM Q4 2016 Sangamo Therapeutics Inc Earnings Release - Before Market Open
Feb 28, 2017 07:03 AM SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P